These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35313995)

  • 21. A QSAR investigation of the role of hydrophobicity in regulating mutagenicity in the Ames test: 1. Mutagenicity of aromatic and heteroaromatic amines in Salmonella typhimurium TA98 and TA100.
    Debnath AK; Debnath G; Shusterman AJ; Hansch C
    Environ Mol Mutagen; 1992; 19(1):37-52. PubMed ID: 1732103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flexible use of QSAR models in predictive toxicology: a case study on aromatic amines.
    Benigni R; Bossa C
    Environ Mol Mutagen; 2012 Jan; 53(1):62-9. PubMed ID: 22329023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of Toxtree and SciQSAR in silico predictive software using a publicly available benchmark mutagenicity database and their applicability for the qualification of impurities in pharmaceuticals.
    Contrera JF
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):285-93. PubMed ID: 23969001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinogenic carbocyclic and heterocyclic aromatic amines: a DFT study concerning their mutagenic potency.
    Borosky GL
    J Mol Graph Model; 2008 Nov; 27(4):459-65. PubMed ID: 18799337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
    Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of published DNA reactivity alerts.
    Myden A; Guesne SJ; Cayley A; Williams RV
    Regul Toxicol Pharmacol; 2017 Aug; 88():77-86. PubMed ID: 28549899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An assessment of mutagenicity of chemical substances by (quantitative) structure-activity relationship.
    Honma M
    Genes Environ; 2020; 42():23. PubMed ID: 32626544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective application of ICH M7 to anti-hypertensive drugs in Brazil: Risk assessment of potentially mutagenic impurities.
    Waechter F; Falcao Oliveira AA; Borges Shimada AL; Bernes Junior E; de Souza Nascimento E
    Regul Toxicol Pharmacol; 2024 Aug; 151():105669. PubMed ID: 38936796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of mutagenicity of monocyclic aromatic amines: quantitative structure-activity relationships.
    Chung KT; Kirkovsky L; Kirkovsky A; Purcell WP
    Mutat Res; 1997 Aug; 387(1):1-16. PubMed ID: 9254889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained.
    Barber C; Cayley A; Hanser T; Harding A; Heghes C; Vessey JD; Werner S; Weiner SK; Wichard J; Giddings A; Glowienke S; Parenty A; Brigo A; Spirkl HP; Amberg A; Kemper R; Greene N
    Regul Toxicol Pharmacol; 2016 Apr; 76():7-20. PubMed ID: 26708083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of false positive, contaminant-driven mutagenicity in impurities associated with the sotorasib drug substance.
    Coppi A; Davies R; Wegesser T; Ishida K; Karmel J; Han J; Aiello F; Xie Y; Corbett MT; Parsons AT; Monticello TM; Minocherhomji S
    Regul Toxicol Pharmacol; 2022 Jun; 131():105162. PubMed ID: 35331777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of 11 in silico models for the prediction of small molecule mutagenicity: role of steric hindrance and electron-withdrawing groups.
    Ford KA; Ryslik G; Chan BK; Lewin-Koh SC; Almeida D; Stokes M; Gomez SR
    Toxicol Mech Methods; 2017 Jan; 27(1):24-35. PubMed ID: 27813437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenic nitrenes/nitrenium ions from azido-imidazoarenes and their structure-activity relationships.
    Wild D; Dirr A
    Mutagenesis; 1989 Nov; 4(6):446-52. PubMed ID: 2695757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment.
    Benigni R; Passerini L
    Mutat Res; 2002 Jul; 511(3):191-206. PubMed ID: 12088717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative stabilities of nitrenium ions derived from polycyclic aromatic amines. Relationship to mutagenicity.
    Ford GP; Herman PS
    Chem Biol Interact; 1992 Jan; 81(1-2):1-18. PubMed ID: 1730143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: structural, electronic, and hydropathic factors affecting mutagenic potency.
    Hatch FT; Knize MG; Colvin ME
    Environ Mol Mutagen; 2001; 38(4):268-91. PubMed ID: 11774358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avoidance of the Ames test liability for aryl-amines via computation.
    McCarren P; Bebernitz GR; Gedeck P; Glowienke S; Grondine MS; Kirman LC; Klickstein J; Schuster HF; Whitehead L
    Bioorg Med Chem; 2011 May; 19(10):3173-82. PubMed ID: 21524589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of aromatic amines with different purities and different solvent vehicles in the Ames test.
    Harding AP; Popelier PL; Harvey J; Giddings A; Foster G; Kranz M
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):244-50. PubMed ID: 25542092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of contradiction between in silico predictions and Ames test results for four pharmaceutically relevant impurities.
    Gunther WC; Kenyon MO; Cheung JR; Dugger RW; Dobo KL
    Regul Toxicol Pharmacol; 2017 Dec; 91():68-76. PubMed ID: 29061373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of rodent carcinogenicity of aromatic amines: a quantitative structure-activity relationships model.
    Franke R; Gruska A; Giuliani A; Benigni R
    Carcinogenesis; 2001 Sep; 22(9):1561-71. PubMed ID: 11532881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.